GoodRx Holdings (GDRX) Share-based Compensation (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Share-based Compensation data on file, last reported at $16.5 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation fell 13.9% year-over-year to $16.5 million; the trailing twelve-month figure through Mar 2026 stood at $74.0 million (down 20.56% YoY), and the FY2025 full-year result was $76.6 million, down 22.62% from the prior year.
• Share-based Compensation retreated to $16.5 million in Q1 2026, from $17.9 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $194.5 million in Q2 2022 to a low of -$23.2 million in Q2 2024.
• A 5-year average of $33.3 million and a median of $25.1 million in 2024 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation soared 2335.21% in 2022 and slumped 229.64% in 2024, its largest moves.
• Tracing GDRX's Share-based Compensation over 5 years: stood at $29.4 million in 2022, then retreated by 2.16% to $28.8 million in 2023, then slipped by 27.17% to $21.0 million in 2024, then dropped by 14.5% to $17.9 million in 2025, then slipped by 7.87% to $16.5 million in 2026.
• Business Quant data shows GDRX's Share-based Compensation at $16.5 million in Q1 2026, $17.9 million in Q4 2025, and $49.6 million in Q3 2025.